Skip to main content
. 2021 Feb 6;14(1):100505. doi: 10.1016/j.waojou.2020.100505

Table 1.

What we know about IgE deficiency.

What we know about IgE deficiency
  • Patients might have no associated symptoms

  • First case of IgE deficiency with no associated symptoms was described in 1970.33

  • May be associated with other immunodeficiencies

  • Ataxia telangiectasia,31 Common Variable Immunodeficiency (CVID),38 IgA deficiency,39 IgG subclass deficiency.40

  • When all other immunoglobulins are normal, the condition is called “Selective IgE deficiency”.

  • Patients might have environmental allergy-like symptoms

  • Environmental allergy-like symptoms (e.g. asthma, rhinosinusitis), were described in different populations28,29,36,38,46

  • Some of these patients have positive type I hypersensitivity reaction skin tests to environmental allergens, despite absent serum IgE levels.47

  • Patients might have non-specific manifestations

  • Fatigue, joints pain28

  • IgE deficient patients have higher rates and risk of malignancy

  • Patients with IgE deficiency have higher rates and risk to develop malignancy, compared with non-IgE deficient individuals.29,34,36,37

  • Those with absent serum IgE and absent cell-bound IgE (negative type I hypersensitivity skin tests) appear to have the highest risk for associated malignancy47

  • New IgE therapies for cancer are under development49